Skip to main content
Top
Gepubliceerd in: Quality of Life Research 10/2015

05-04-2015

Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D

Auteurs: Ji Young Hong, Song Yee Kim, Kyung Soo Chung, Eun Young Kim, Ji Ye Jung, Moo Suk Park, Young Ae Kang, Se Kyu Kim, Joon Chang, Young Sam Kim

Gepubliceerd in: Quality of Life Research | Uitgave 10/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

This study evaluated the health-related quality of life measured using the EuroQol five-dimension questionnaire (EQ-5D) and the degree of airway obstruction in a Korean population using Korea National Health and Nutritional Examination Survey (KNHANES IV–V, 2007–2010) data.

Methods

A cross-sectional analysis examined 2356 subjects (1178 COPD patients, 1178 control subjects) aged ≥40 years and performed reliable spirometry as part of KNHANES IV–V. Baseline EQ-5D visual analog scale (VAS) and EQ-5D utility scores were obtained. A Tobit censored regression model was used to evaluate factors affecting EQ-5D in COPD patients.

Results

The EQ-5D VAS and EQ-5D utility scores were significantly different among the COPD severity groups (P < 0.05). The mean EQ-5D VAS scores for patients with mild, moderate, and severe COPD were 73.0 (SD 18.6), 70.8 (19.1), and 60.9 (23.4), respectively. The mean utility scores were 0.90 (0.14) for patients with mild COPD, 0.89 (0.14) for patients with moderate COPD, and 0.84 (0.15) for patients with severe COPD. Factors influencing the EQ-5D utility score in patients with COPD were age, gender, household income, education level, severe airflow obstruction, and comorbidities.

Conclusions

The EQ-5D score could be a useful instrument for evaluating the quality of life of COPD patients in Korea. In Korean COPD patients, the main determinants of EQ-5D scores include older age, female gender, lower household income, lower education level, severe airflow obstruction, and many comorbid diseases.
Literatuur
1.
go back to reference Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease—GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176(6), 532–555.CrossRefPubMed Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease—GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176(6), 532–555.CrossRefPubMed
2.
go back to reference Decramer, M., Sibille, Y., Bush, A., Carlsen, K. H., Rabe, K. F., Clancy, L., et al. (2011). The European Union conference on chronic respiratory disease: Purpose and conclusions. European Respiratory Journal, 37(4), 738–742.CrossRefPubMed Decramer, M., Sibille, Y., Bush, A., Carlsen, K. H., Rabe, K. F., Clancy, L., et al. (2011). The European Union conference on chronic respiratory disease: Purpose and conclusions. European Respiratory Journal, 37(4), 738–742.CrossRefPubMed
3.
go back to reference Vestbo, J., Hurd, S. S., Agusti, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., et al. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 187(4), 347–365.CrossRefPubMed Vestbo, J., Hurd, S. S., Agusti, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., et al. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 187(4), 347–365.CrossRefPubMed
4.
go back to reference Decramer, M., Celli, B., Kesten, S., Lystig, T., Mehra, S., & Tashkin, D. P. (2009). Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): A prespecified subgroup analysis of a randomised controlled trial. Lancet, 374(9696), 1171–1178.CrossRefPubMed Decramer, M., Celli, B., Kesten, S., Lystig, T., Mehra, S., & Tashkin, D. P. (2009). Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): A prespecified subgroup analysis of a randomised controlled trial. Lancet, 374(9696), 1171–1178.CrossRefPubMed
5.
go back to reference Jenkins, C. R., Jones, P. W., Calverley, P. M., Celli, B., Anderson, J. A., Ferguson, G. T., et al. (2009). Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH study. Respiratory Research, 10, 59.PubMedCentralCrossRefPubMed Jenkins, C. R., Jones, P. W., Calverley, P. M., Celli, B., Anderson, J. A., Ferguson, G. T., et al. (2009). Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH study. Respiratory Research, 10, 59.PubMedCentralCrossRefPubMed
7.
go back to reference Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.CrossRefPubMed Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.CrossRefPubMed
8.
go back to reference Carrasco Garrido, P., de Miguel Diez, J., Rejas Gutierrez, J., Centeno, A. M., Gobartt Vazquez, E., Gil de Miguel, A., et al. (2006). Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health and Quality of Life Outcomes, 4, 31.CrossRefPubMed Carrasco Garrido, P., de Miguel Diez, J., Rejas Gutierrez, J., Centeno, A. M., Gobartt Vazquez, E., Gil de Miguel, A., et al. (2006). Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health and Quality of Life Outcomes, 4, 31.CrossRefPubMed
9.
go back to reference Rutten-van, M. P. M., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest, 130(4), 1117–1128.CrossRef Rutten-van, M. P. M., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest, 130(4), 1117–1128.CrossRef
10.
go back to reference Ferrer, M., Alonso, J., Morera, J., Marrades, R. M., Khalaf, A., Aguar, M. C., et al. (1997). Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group. Annals of Internal Medicine, 127(12), 1072–1079.CrossRefPubMed Ferrer, M., Alonso, J., Morera, J., Marrades, R. M., Khalaf, A., Aguar, M. C., et al. (1997). Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group. Annals of Internal Medicine, 127(12), 1072–1079.CrossRefPubMed
11.
go back to reference DiBonaventura, M., Paulose-Ram, R., Su, J., McDonald, M., Zou, K. H., Wagner, J. S., et al. (2012). The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. COPD, 9(1), 46–57.CrossRefPubMed DiBonaventura, M., Paulose-Ram, R., Su, J., McDonald, M., Zou, K. H., Wagner, J. S., et al. (2012). The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. COPD, 9(1), 46–57.CrossRefPubMed
12.
go back to reference Burgel, P. R., Escamilla, R., Perez, T., Carre, P., Caillaud, D., Chanez, P., et al. (2013). Impact of comorbidities on COPD-specific health-related quality of life. Respiratory Medicine, 107(2), 233–241.CrossRefPubMed Burgel, P. R., Escamilla, R., Perez, T., Carre, P., Caillaud, D., Chanez, P., et al. (2013). Impact of comorbidities on COPD-specific health-related quality of life. Respiratory Medicine, 107(2), 233–241.CrossRefPubMed
13.
go back to reference Weldam, S. W., Lammers, J. W., Decates, R. L., & Schuurmans, M. J. (2013). Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: Psychological determinants: A cross-sectional study. Health and Quality of Life Outcomes, 11, 190.PubMedCentralCrossRefPubMed Weldam, S. W., Lammers, J. W., Decates, R. L., & Schuurmans, M. J. (2013). Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: Psychological determinants: A cross-sectional study. Health and Quality of Life Outcomes, 11, 190.PubMedCentralCrossRefPubMed
14.
go back to reference Popa-Velea, O., & Purcarea, V. (2014). Psychological factors mediating health-related quality of life in COPD. Journal of Medicine and Life, 7(1), 100–103.PubMedCentralPubMed Popa-Velea, O., & Purcarea, V. (2014). Psychological factors mediating health-related quality of life in COPD. Journal of Medicine and Life, 7(1), 100–103.PubMedCentralPubMed
15.
go back to reference Yoo, K. H., Kim, Y. S., Sheen, S. S., Park, J. H., Hwang, Y. I., Kim, S. H., et al. (2011). Prevalence of chronic obstructive pulmonary disease in Korea: The fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology, 16(4), 659–665.CrossRefPubMed Yoo, K. H., Kim, Y. S., Sheen, S. S., Park, J. H., Hwang, Y. I., Kim, S. H., et al. (2011). Prevalence of chronic obstructive pulmonary disease in Korea: The fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology, 16(4), 659–665.CrossRefPubMed
16.
go back to reference Kim, S. H., Oh, Y. M., & Jo, M. W. (2014). Health-related quality of life in chronic obstructive pulmonary disease patients in Korea. Health and Quality of Life Outcomes, 12, 57.PubMedCentralCrossRefPubMed Kim, S. H., Oh, Y. M., & Jo, M. W. (2014). Health-related quality of life in chronic obstructive pulmonary disease patients in Korea. Health and Quality of Life Outcomes, 12, 57.PubMedCentralCrossRefPubMed
17.
go back to reference Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. (2007). Standardisation of spirometry. Revue des Maladies Respiratoires, 24(3), S27–S49.CrossRef Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. (2007). Standardisation of spirometry. Revue des Maladies Respiratoires, 24(3), S27–S49.CrossRef
18.
go back to reference Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.CrossRefPubMed
20.
go back to reference group E. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef group E. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
21.
go back to reference Lee, Y. K., Nam, H. S., Chuang, L. H., Kim, K. Y., Yang, H. K., Kwon, I. S., et al. (2009). South Korean time trade-off values for EQ-5D health states: Modeling with observed values for 101 health states. Value in Health, 12(8), 1187–1193.CrossRefPubMed Lee, Y. K., Nam, H. S., Chuang, L. H., Kim, K. Y., Yang, H. K., Kwon, I. S., et al. (2009). South Korean time trade-off values for EQ-5D health states: Modeling with observed values for 101 health states. Value in Health, 12(8), 1187–1193.CrossRefPubMed
22.
go back to reference Pickard, A. S., Yang, Y., & Lee, T. A. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes, 9, 26.PubMedCentralCrossRefPubMed Pickard, A. S., Yang, Y., & Lee, T. A. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes, 9, 26.PubMedCentralCrossRefPubMed
23.
go back to reference Jones, P. W., Quirk, F. H., Baveystock, C. M. (1991). The St George’s Respiratory Questionnaire. Respir Med, 85 Suppl B, 25–31; discussion 33–27. Jones, P. W., Quirk, F. H., Baveystock, C. M. (1991). The St George’s Respiratory Questionnaire. Respir Med, 85 Suppl B, 25–31; discussion 33–27.
24.
go back to reference Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes, 5, 21.PubMedCentralCrossRefPubMed Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes, 5, 21.PubMedCentralCrossRefPubMed
25.
go back to reference Punekar, Y. S., Rodriguez-Roisin, R., Sculpher, M., Jones, P., & Spencer, M. (2007). Implications of chronic obstructive pulmonary disease (COPD) on patients’ health status: A western view. Respiratory Medicine, 101(3), 661–669.CrossRefPubMed Punekar, Y. S., Rodriguez-Roisin, R., Sculpher, M., Jones, P., & Spencer, M. (2007). Implications of chronic obstructive pulmonary disease (COPD) on patients’ health status: A western view. Respiratory Medicine, 101(3), 661–669.CrossRefPubMed
26.
go back to reference Antonelli-Incalzi, R., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., et al. (2003). Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal, 22(3), 444–449.CrossRefPubMed Antonelli-Incalzi, R., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., et al. (2003). Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal, 22(3), 444–449.CrossRefPubMed
27.
go back to reference Yeo, J., Karimova, G., & Bansal, S. (2006). Co-morbidity in older patients with COPD—its impact on health service utilisation and quality of life, a community study. Age and Ageing, 35(1), 33–37.CrossRefPubMed Yeo, J., Karimova, G., & Bansal, S. (2006). Co-morbidity in older patients with COPD—its impact on health service utilisation and quality of life, a community study. Age and Ageing, 35(1), 33–37.CrossRefPubMed
28.
go back to reference Ketelaars, C. A., Schlosser, M. A., Mostert, R., Huyer Abu-Saad, H., Halfens, R. J., & Wouters, E. F. (1996). Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 51(1), 39–43.PubMedCentralCrossRefPubMed Ketelaars, C. A., Schlosser, M. A., Mostert, R., Huyer Abu-Saad, H., Halfens, R. J., & Wouters, E. F. (1996). Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 51(1), 39–43.PubMedCentralCrossRefPubMed
29.
go back to reference Carrasco-Garrido, P., de Miguel-Diez, J., Rejas-Gutierrez, J., Martin-Centeno, A., Gobartt-Vazquez, E., Hernandez-Barrera, V., et al. (2009). Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulmonary Medicine, 9, 2.PubMedCentralCrossRefPubMed Carrasco-Garrido, P., de Miguel-Diez, J., Rejas-Gutierrez, J., Martin-Centeno, A., Gobartt-Vazquez, E., Hernandez-Barrera, V., et al. (2009). Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulmonary Medicine, 9, 2.PubMedCentralCrossRefPubMed
30.
go back to reference Naberan, K., Azpeitia, A., Cantoni, J., & Miravitlles, M. (2012). Impairment of quality of life in women with chronic obstructive pulmonary disease. Respiratory Medicine, 106(3), 367–373.CrossRefPubMed Naberan, K., Azpeitia, A., Cantoni, J., & Miravitlles, M. (2012). Impairment of quality of life in women with chronic obstructive pulmonary disease. Respiratory Medicine, 106(3), 367–373.CrossRefPubMed
31.
go back to reference Miravitlles, M., Naberan, K., Cantoni, J., & Azpeitia, A. (2011). Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration, 82(5), 402–408.CrossRefPubMed Miravitlles, M., Naberan, K., Cantoni, J., & Azpeitia, A. (2011). Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration, 82(5), 402–408.CrossRefPubMed
32.
go back to reference Johannessen, A., Eagan, T. M., Omenaas, E. R., Bakke, P. S., & Gulsvik, A. (2010). Socioeconomic risk factors for lung function decline in a general population. European Respiratory Journal, 36(3), 480–487.CrossRefPubMed Johannessen, A., Eagan, T. M., Omenaas, E. R., Bakke, P. S., & Gulsvik, A. (2010). Socioeconomic risk factors for lung function decline in a general population. European Respiratory Journal, 36(3), 480–487.CrossRefPubMed
33.
go back to reference Tsukino, M., Nishimura, K., Ikeda, A., Koyama, H., Mishima, M., & Izumi, T. (1996). Physiologic factors that determine the health-related quality of life in patients with COPD. Chest, 110(4), 896–903.CrossRefPubMed Tsukino, M., Nishimura, K., Ikeda, A., Koyama, H., Mishima, M., & Izumi, T. (1996). Physiologic factors that determine the health-related quality of life in patients with COPD. Chest, 110(4), 896–903.CrossRefPubMed
34.
go back to reference Stahl, E., Lindberg, A., Jansson, S. A., Ronmark, E., Svensson, K., Andersson, F., et al. (2005). Health-related quality of life is related to COPD disease severity. Health and Quality of Life Outcomes, 3, 56.PubMedCentralCrossRefPubMed Stahl, E., Lindberg, A., Jansson, S. A., Ronmark, E., Svensson, K., Andersson, F., et al. (2005). Health-related quality of life is related to COPD disease severity. Health and Quality of Life Outcomes, 3, 56.PubMedCentralCrossRefPubMed
35.
go back to reference Jackson, B. E., Coultas, D. B., Suzuki, S., Singh, K. P., & Bae, S. (2013). Rural-urban disparities in quality of life among patients with COPD. The Journal of Rural Health, 29(Suppl 1), s62–s69.PubMedCentralCrossRefPubMed Jackson, B. E., Coultas, D. B., Suzuki, S., Singh, K. P., & Bae, S. (2013). Rural-urban disparities in quality of life among patients with COPD. The Journal of Rural Health, 29(Suppl 1), s62–s69.PubMedCentralCrossRefPubMed
36.
go back to reference Wilke, S., Janssen, D. J., Wouters, E. F., Schols, J. M., Franssen, F. M., & Spruit, M. A. (2012). Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: A one-year observational study. Health and Quality of Life Outcomes, 10, 98.PubMedCentralCrossRefPubMed Wilke, S., Janssen, D. J., Wouters, E. F., Schols, J. M., Franssen, F. M., & Spruit, M. A. (2012). Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: A one-year observational study. Health and Quality of Life Outcomes, 10, 98.PubMedCentralCrossRefPubMed
Metagegevens
Titel
Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D
Auteurs
Ji Young Hong
Song Yee Kim
Kyung Soo Chung
Eun Young Kim
Ji Ye Jung
Moo Suk Park
Young Ae Kang
Se Kyu Kim
Joon Chang
Young Sam Kim
Publicatiedatum
05-04-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-0979-6

Andere artikelen Uitgave 10/2015

Quality of Life Research 10/2015 Naar de uitgave